Search results
Results from the WOW.Com Content Network
Oral submucous fibrosis (OSF) is a chronic, complex, premalignant (1% transformation risk) condition of the oral cavity, characterized by juxta-epithelial inflammatory reaction and progressive fibrosis of the submucosal tissues (the lamina propria and deeper connective tissues). As the disease progresses, the oral mucosa becomes fibrotic to the ...
Using dipping tobacco can cause a number of adverse health effects such as dental disease, oral cancer, oesophagus cancer, and pancreatic cancer, cardiovascular disease, asthma, and deformities in the female reproductive system. [13] It also raises the risk of fatal coronary artery disease, fatal stroke and non-fatal ischaemic heart disease [14 ...
The consumption of tobacco products and its harmful effects affect both smokers and non-smokers, [9] and is a major risk factor for six of the eight leading causes of deaths in the world, including respiratory diseases, cardiovascular diseases, cerebrovascular diseases, periodontal diseases, teeth decay and loss, over 20 different types or subtypes of cancers, strokes, several debilitating ...
Chewing tobacco is a cause of oral cancer, oesophagus cancer, and pancreas cancer. [20] Increased risk of oral cancer caused by chewing tobacco is present in countries such as the United States but particularly prevalent in Southeast Asian countries where the use of smokeless tobacco is common. [21] [22] All tobacco products, including chewing ...
“Excessive chewing can lead to problems with the joint of the jaw, known as temporomandibular joint dysfunction (TMD),” Gary Liu, a board-certified pediatric dentist, cautions.
"Mewing results in forcefully pressing the tongue against the roof of the mouth repeatedly and frequently, which promotes an unhealthy range of motion within the TMJ (temporomandibular joint ...
In patients taking drugs for cancer, the likelihood of MRONJ development varies from 0 - 12%. This again, varies with the type of cancer, although prostate cancer and multiple myeloma are reported to be at a higher risk. [8] In patients taking oral drugs for osteoporosis, the likelihood of MRONJ development varies from 0 - 0.2%. [7]
For premium support please call: 800-290-4726 more ways to reach us